Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Antibody–drug conjugates: Recent advances in payloads
Zhijia Wang, Hanxuan Li, Lantu Gou, et al.
Acta Pharmaceutica Sinica B (2023) Vol. 13, Iss. 10, pp. 4025-4059
Open Access | Times Cited: 76

Showing 26-50 of 76 citing articles:

Charting the Course in Sequencing Antibody-Drug Conjugates in Breast Cancer
Giuseppe Saltalamacchia, Rosalba Torrisi, Rita De Sanctis, et al.
Biomedicines (2024) Vol. 12, Iss. 3, pp. 500-500
Open Access | Times Cited: 3
The therapeutic potential of natural metabolites in targeting endocrine-independent HER-2-negative breast cancer
Mirosława Püsküllüoğlu, Izabela Michalak
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 3
A novel shark VNAR antibody-based immunotoxin targeting TROP-2 for cancer therapy
Xiaozhi Xi, Yanqing Wang, Guiqi An, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 11, pp. 4806-4818
Open Access | Times Cited: 3
Next-Generation Therapeutic Antibodies for Cancer Treatment: Advancements, Applications, and Challenges
A. Raja, Abhishek Kasana, Vaishali Verma
Molecular Biotechnology (2024)
Closed Access | Times Cited: 3
Discovery of novel HER2 targeting peptide-camptothecin conjugates with effective suppression for selective cancer treatment
Hanyu Wu, Yunxiao Liu, Jiaqi Zhou, et al.
Bioorganic Chemistry (2024) Vol. 147, pp. 107371-107371
Closed Access | Times Cited: 3
Antibody drug conjugates in the clinic
Edidiong Udofa, Disha Sankholkar, Samir Mitragotri, et al.
Bioengineering & Translational Medicine (2024) Vol. 9, Iss. 6
Open Access | Times Cited: 2
Single-Domain Antibodies as Antibody–Drug Conjugates: From Promise to Practice—A Systematic Review
Víctor Manuel Medina Pérez, Marta Baselga, Alberto J. Schuhmacher
Cancers (2024) Vol. 16, Iss. 15, pp. 2681-2681
Open Access | Times Cited: 2
Antibody Drug Conjugates for Cancer Therapy: From Metallodrugs to Nature-Inspired Payloads
Giovanni Tonon, Flavio Rizzolio, Fabiano Visentin, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 16, pp. 8651-8651
Open Access | Times Cited: 2
Identifying and characterising promising small molecule inhibitors of kinesin spindle protein using ligand-based virtual screening, molecular docking, molecular dynamics and MM‑GBSA calculations
Samia A. Elseginy
Journal of Computer-Aided Molecular Design (2024) Vol. 38, Iss. 1
Open Access | Times Cited: 1
Revolutionizing Cancer Treatment - The Emergence and Impact of Antibody-Drug Conjugates (ADCs): A Systematic Review
Christopher Korban, Omar Fayaz, Aryan Kohli, et al.
(2024)
Open Access | Times Cited: 1
Development of small molecule–drug conjugates based on derivatives of natural proteasome inhibitors that exhibit selectivity for PSMA-expressing cancer cells
T. Obara, N. Kawano, Kengo Tatsumi, et al.
Bioorganic & Medicinal Chemistry (2024) Vol. 108, pp. 117773-117773
Closed Access | Times Cited: 1
Efficacy and safety of antibody–drug conjugates in the treatment of urothelial cell carcinoma: a systematic review and meta-analysis of prospective clinical trials
Junwei Ren, Zeyu Chen, Yunjin Bai, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 1
Target Identification and Mechanistic Characterization of Indole Terpenoid Mimics: Proper Spindle Microtubule Assembly Is Essential for Cdh1‐Mediated Proteolysis of CENP‐A
Yan Peng, Yumeng Zhang, Fang Ruan, et al.
Advanced Science (2024) Vol. 11, Iss. 29
Open Access | Times Cited: 1
Antibody-drug conjugates for non-small cell lung cancer: Advantages and challenges in clinical translation
Chenyu Zhao, Ruihan Zhang, Huazhe Yang, et al.
Biochemical Pharmacology (2024) Vol. 226, pp. 116378-116378
Closed Access | Times Cited: 1
Antibody–Drug Conjugates—Evolution and Perspectives
Adriana Aurelia Chiş, Carmen Maximiliana Dobrea, Anca Maria Arseniu, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 13, pp. 6969-6969
Open Access | Times Cited: 1
Beyond Cytotoxic Potency: Disposition Features Required to Design ADC Payload
Hao Sun, Larry C. Wienkers, Anthony Lee
Xenobiotica (2024) Vol. 54, Iss. 8, pp. 442-457
Closed Access | Times Cited: 1
Risk Assessment and Control of N-Nitrosamines in Antibody–Drug Conjugates: Current Industry Practices
Paul G. Bulger, Michael T. Jones, J. Gair Ford, et al.
Organic Process Research & Development (2024) Vol. 28, Iss. 8, pp. 3078-3084
Closed Access | Times Cited: 1
Therapeutic antibodies in oncology: an immunopharmacological overview
Karen Toledo‐Stuardo, Carolina Ribeiro, Fabiola González‐Herrera, et al.
Cancer Immunology Immunotherapy (2024) Vol. 73, Iss. 12
Open Access | Times Cited: 1
Dual-payload Antibody–drug Conjugates: Taking a Dual Shot
Junjie Tao, Yilin Gu, Wei Zhou, et al.
European Journal of Medicinal Chemistry (2024) Vol. 281, pp. 116995-116995
Closed Access | Times Cited: 1
The journey of antibody-drug conjugates for revolutionizing cancer therapy: A review
Fatima Akram, Amna M. Ali, Muhammad Tayyab Akhtar, et al.
Bioorganic & Medicinal Chemistry (2024) Vol. 117, pp. 118010-118010
Closed Access | Times Cited: 1
Exo-Cleavable Linkers: A Paradigm Shift for Enhanced Stability and Therapeutic Efficacy in Antibody-Drug Conjugates
Tomohiro Watanabe, Naoko Arashida, Tomohiro Fujii, et al.
(2023)
Open Access | Times Cited: 3
Development of a Cytotoxic Antibody–Drug Conjugate Targeting Membrane Immunoglobulin E-Positive Cells
Aleksandra Rodak, Katharina Stadlbauer, Madhusudhan Reddy Bobbili, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 19, pp. 14997-14997
Open Access | Times Cited: 3
The ABC of ADCs (Antibody-Drug Conjugates): A Comprehensive Review of Technical, Regulatory, and Clinical Challenges
Kishore Kumar Hotha
Advances in Chemical Engineering and Science (2023) Vol. 13, Iss. 04, pp. 363-381
Open Access | Times Cited: 2
Generation and Characterization of SORT1-Targeted Antibody–Drug Conjugate for the Treatment of SORT1-Positive Breast Tumor
Weiliang Zhuang, Wei Zhang, Liping Xie, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 24, pp. 17631-17631
Open Access | Times Cited: 2
Design, synthesis and bioactivity evaluation of novel monomethyl auristatin F analogues
Lisheng Yang, Xinglin Li, Lei Zhao, et al.
Research Square (Research Square) (2024)
Open Access

Scroll to top